India High Court Orders GSK Unit To Pay 20-Year-Old Pricing Fine
This article was originally published in PharmAsia News
Executive Summary
India's highest court ordered Glaxo India, a unit of U.K.-based GlaxoSmithKline, to pay $16 million to cover a 20-year-old pricing dispute with the government